Current understanding of resistance to abiraterone and enzalutamide in advanced prostate cancer

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	316-319
Number of pages	4
Journal	Clinical Advances in Hematology and Oncology
Volume	14
Issue number	5
State	Published - May 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{e49cd224d2034a2f93b62f917dda55a6,

title = "Current understanding of resistance to abiraterone and enzalutamide in advanced prostate cancer",

author = "Antonarakis, {Emmanuel S.}",

year = "2016",

month = may,

language = "English (US)",

volume = "14",

pages = "316--319",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "5",

}

TY - JOUR

T1 - Current understanding of resistance to abiraterone and enzalutamide in advanced prostate cancer

AU - Antonarakis, Emmanuel S.

PY - 2016/5

Y1 - 2016/5

UR - http://www.scopus.com/inward/record.url?scp=84966539972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966539972&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 27379691

AN - SCOPUS:84966539972

SN - 1543-0790

VL - 14

SP - 316

EP - 319

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 5

ER -